DK1648484T3 - Fremgangsmåde til behandling af arthritis-tilstande - Google Patents
Fremgangsmåde til behandling af arthritis-tilstandeInfo
- Publication number
- DK1648484T3 DK1648484T3 DK04735566T DK04735566T DK1648484T3 DK 1648484 T3 DK1648484 T3 DK 1648484T3 DK 04735566 T DK04735566 T DK 04735566T DK 04735566 T DK04735566 T DK 04735566T DK 1648484 T3 DK1648484 T3 DK 1648484T3
- Authority
- DK
- Denmark
- Prior art keywords
- treating arthritis
- arthritis conditions
- conditions
- acid
- arthritis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001311A ITMI20031311A1 (it) | 2003-06-27 | 2003-06-27 | Formulazioni per il trattamento di disturbi artrosici. |
| PCT/EP2004/005875 WO2005002611A1 (en) | 2003-06-27 | 2004-06-01 | Formulations for the treatment of arhritis conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1648484T3 true DK1648484T3 (da) | 2009-01-19 |
Family
ID=30131307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04735566T DK1648484T3 (da) | 2003-06-27 | 2004-06-01 | Fremgangsmåde til behandling af arthritis-tilstande |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8343554B2 (ko) |
| EP (1) | EP1648484B1 (ko) |
| JP (1) | JP2007513051A (ko) |
| KR (2) | KR101119418B1 (ko) |
| CN (1) | CN1812802A (ko) |
| AT (1) | ATE414526T1 (ko) |
| AU (1) | AU2004253242B2 (ko) |
| BR (1) | BRPI0411895B1 (ko) |
| CA (1) | CA2530494C (ko) |
| DE (1) | DE602004017871D1 (ko) |
| DK (1) | DK1648484T3 (ko) |
| ES (1) | ES2315662T3 (ko) |
| IL (1) | IL172773A (ko) |
| IT (1) | ITMI20031311A1 (ko) |
| NO (1) | NO333877B1 (ko) |
| NZ (1) | NZ544400A (ko) |
| PL (1) | PL1648484T3 (ko) |
| PT (1) | PT1648484E (ko) |
| RU (1) | RU2349336C2 (ko) |
| SI (1) | SI1648484T1 (ko) |
| WO (1) | WO2005002611A1 (ko) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20040439A1 (it) * | 2004-09-16 | 2004-12-16 | Ca Di Group S R L | Prodotto con azione antinfiammatoria selettiva e azione contro la fibrogenesi tissutale. |
| ITMI20051349A1 (it) * | 2005-07-14 | 2007-01-15 | Indena Spa | Estratto di salice uso e formulazioni che lo contengono |
| CN100417415C (zh) * | 2006-06-28 | 2008-09-10 | 文彦春 | 浸润治疗关节炎的药物 |
| EP1886712A1 (en) | 2006-08-08 | 2008-02-13 | Indena S.P.A. | Compositions for the treatment of chronic degenerative inflammatory conditions |
| FR2907339B1 (fr) * | 2006-10-20 | 2009-04-24 | Inneov Lab | Composition comprenant de la glucosamine et au moins un polyphenol. |
| CN101371823B (zh) * | 2007-03-19 | 2010-09-15 | 上海慈瑞医药科技有限公司 | 二乙酰大黄酸缓释胶囊的制备工艺 |
| FR2918376B1 (fr) | 2007-07-04 | 2011-10-28 | Mathieu Borge | Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage |
| EP2182967A1 (en) * | 2007-09-04 | 2010-05-12 | Catholic University Industry Academic Cooperation Foundation | Process for preparing vitis vinifera pip extract and pharmaceutical composition for preventing or treating rheumatoid arthritis comprising the same |
| EA025110B1 (ru) | 2008-09-15 | 2016-11-30 | Лайла Нутрасьютикалс | Синергичные противовоспалительные композиции, содержащие экстракты boswellia serrata |
| KR101096574B1 (ko) * | 2008-12-12 | 2011-12-20 | 에이치 엘 지노믹스(주) | 유럽종 포도의 씨 추출물을 함유하는 골다공증 예방 또는 치료용 약학 조성물 |
| KR101099021B1 (ko) * | 2009-04-24 | 2011-12-28 | 에이치 엘 지노믹스(주) | 유럽종 포도의 씨 추출물을 함유하는 골관절염 예방 또는 치료용 약학 조성물 |
| JP5734578B2 (ja) * | 2009-09-03 | 2015-06-17 | ナガセケムテックス株式会社 | ヒアルロン酸増量剤 |
| WO2011079203A1 (en) * | 2009-12-23 | 2011-06-30 | Bae Systems Aerospace & Defense Group Inc. | Quick release buckle with dual release |
| CA2786230A1 (en) | 2010-02-15 | 2011-08-18 | Laila Nutraceuticals | A novel boswellia low polar gum resin extract and its synergistic compositions |
| US8828377B2 (en) | 2010-03-15 | 2014-09-09 | Laila Nutraceuticals | Boswellia oil, its fractions and compositions for enhancing brain function |
| EP2723357A4 (en) | 2011-06-21 | 2015-04-01 | Bvw Holding Ag | MEDICAL DEVICE COMPRISING BOSWELLIC ACID |
| RU2476213C1 (ru) * | 2012-02-15 | 2013-02-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия имени Н.Н. Бурденко Министерства здравоохранения и социального развития" (ГБОУ ВПО ВГМА им. Н.Н. Бурденко Минздравсоцразвития России) | Способ комплексного лечения вторичного остеоартроза при ревматоидном артрите |
| JP6270362B2 (ja) * | 2013-07-17 | 2018-01-31 | 日本水産株式会社 | 関節痛改善剤 |
| JP6153436B2 (ja) * | 2013-09-27 | 2017-06-28 | 小林製薬株式会社 | 経口組成物 |
| US9975917B1 (en) | 2017-09-20 | 2018-05-22 | King Saud University | Pentacyclic triterpenoidal derivatives |
| CN111110863A (zh) * | 2020-01-21 | 2020-05-08 | 郑州大学 | 大黄酸磷脂复合物及其制备方法和应用、大黄酸磷脂复合物长循环脂质体及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3970M (ko) | 1963-11-26 | 1966-02-28 | ||
| DE1543307B2 (de) * | 1965-06-26 | 1971-03-18 | Ajinomoto Co Ine Tokio | Haerten von epoxyharzen |
| DE3347522A1 (de) * | 1983-12-30 | 1985-07-11 | Troponwerke GmbH & Co KG, 5000 Köln | N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises |
| DE3602670A1 (de) | 1986-01-29 | 1987-07-30 | Speck Ulrich | Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen |
| US5629351A (en) | 1995-04-13 | 1997-05-13 | Council Of Scientific & Industrial Research | Boswellic acid compositions and preparation thereof |
| DE19531067A1 (de) | 1995-08-23 | 1997-02-27 | Hermann P T Prof Dr Med Ammon | Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität |
| US5762936A (en) * | 1996-09-04 | 1998-06-09 | Biotics Research Corporation | Antioxidant derived from lentil and its preparation and uses |
| JP4153057B2 (ja) | 1997-03-10 | 2008-09-17 | 中国化薬株式会社 | Ｄ−グルクロノラクトンの製造方法 |
| US6107334A (en) * | 1998-02-23 | 2000-08-22 | Wake Forest University | Dietary control of arachidonic acid metabolism |
| US6761903B2 (en) * | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
| MXPA01011606A (es) * | 1999-05-14 | 2003-09-10 | Univ California | Terapia anti-inflamatoria para infeccion mediada por inflamacion. |
| JP2002153294A (ja) * | 2000-11-21 | 2002-05-28 | Hayashibara Biochem Lab Inc | グルクロン酸類及び／又はｄ−グルクロノラクトンの製造方法とその用途 |
| US6451045B1 (en) * | 2001-02-22 | 2002-09-17 | Alsius Corporation | Heat exchange catheter having a helically wrapped heat exchanger |
| US6541045B1 (en) * | 2002-01-04 | 2003-04-01 | Nutraceutical Corporation | Herbal composition and method for combating inflammation |
-
2003
- 2003-06-27 IT IT001311A patent/ITMI20031311A1/it unknown
-
2004
- 2004-01-06 US US10/562,205 patent/US8343554B2/en not_active Expired - Fee Related
- 2004-06-01 DE DE602004017871T patent/DE602004017871D1/de not_active Expired - Lifetime
- 2004-06-01 PL PL04735566T patent/PL1648484T3/pl unknown
- 2004-06-01 ES ES04735566T patent/ES2315662T3/es not_active Expired - Lifetime
- 2004-06-01 RU RU2005140573/15A patent/RU2349336C2/ru not_active IP Right Cessation
- 2004-06-01 WO PCT/EP2004/005875 patent/WO2005002611A1/en active Application Filing
- 2004-06-01 CN CNA2004800177557A patent/CN1812802A/zh active Pending
- 2004-06-01 DK DK04735566T patent/DK1648484T3/da active
- 2004-06-01 KR KR1020057024594A patent/KR101119418B1/ko active IP Right Grant
- 2004-06-01 AU AU2004253242A patent/AU2004253242B2/en not_active Ceased
- 2004-06-01 JP JP2006515812A patent/JP2007513051A/ja active Pending
- 2004-06-01 CA CA2530494A patent/CA2530494C/en not_active Expired - Fee Related
- 2004-06-01 NZ NZ544400A patent/NZ544400A/en unknown
- 2004-06-01 KR KR1020117007487A patent/KR20110039400A/ko not_active Application Discontinuation
- 2004-06-01 SI SI200430968T patent/SI1648484T1/sl unknown
- 2004-06-01 BR BRPI0411895A patent/BRPI0411895B1/pt not_active IP Right Cessation
- 2004-06-01 EP EP04735566A patent/EP1648484B1/en not_active Expired - Lifetime
- 2004-06-01 AT AT04735566T patent/ATE414526T1/de active
- 2004-06-01 PT PT04735566T patent/PT1648484E/pt unknown
-
2005
- 2005-12-22 IL IL172773A patent/IL172773A/en active IP Right Grant
- 2005-12-23 NO NO20056161A patent/NO333877B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0411895A (pt) | 2006-08-29 |
| PT1648484E (pt) | 2009-01-09 |
| RU2005140573A (ru) | 2006-06-10 |
| NZ544400A (en) | 2009-04-30 |
| IL172773A (en) | 2010-12-30 |
| ATE414526T1 (de) | 2008-12-15 |
| NO20056161L (no) | 2005-12-23 |
| BRPI0411895B1 (pt) | 2015-11-10 |
| PL1648484T3 (pl) | 2009-04-30 |
| US8343554B2 (en) | 2013-01-01 |
| SI1648484T1 (sl) | 2009-02-28 |
| ITMI20031311A0 (it) | 2003-06-27 |
| ITMI20031311A1 (it) | 2004-12-28 |
| KR20110039400A (ko) | 2011-04-15 |
| JP2007513051A (ja) | 2007-05-24 |
| KR20060032147A (ko) | 2006-04-14 |
| ES2315662T3 (es) | 2009-04-01 |
| NO333877B1 (no) | 2013-10-07 |
| KR101119418B1 (ko) | 2012-02-22 |
| CA2530494A1 (en) | 2005-01-13 |
| WO2005002611A1 (en) | 2005-01-13 |
| US20060280811A1 (en) | 2006-12-14 |
| AU2004253242B2 (en) | 2010-02-18 |
| AU2004253242A1 (en) | 2005-01-13 |
| CN1812802A (zh) | 2006-08-02 |
| EP1648484B1 (en) | 2008-11-19 |
| CA2530494C (en) | 2013-04-30 |
| RU2349336C2 (ru) | 2009-03-20 |
| DE602004017871D1 (de) | 2009-01-02 |
| EP1648484A1 (en) | 2006-04-26 |
| IL172773A0 (en) | 2006-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1648484T3 (da) | Fremgangsmåde til behandling af arthritis-tilstande | |
| DK1420801T3 (da) | Anvendelse af fucaner til behandling af adhæsioner, arthritis og psoreasis | |
| DK1494692T3 (da) | Topiske, farmaceutiske sammensætninger, der omfatter proanthocyanidiner, glycyrrhetinsyre og telmestein til behandlingen af dermatitis | |
| TW200510416A (en) | P38 inhibitors and methods of use thereof | |
| PT1297851E (pt) | Inibicao de histona-desacetilase como tratamento para hipertrofia cardiaca | |
| BR0308787A (pt) | Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona | |
| NO20090157L (no) | Tienpyrimidiner anvendelige som modulatorer av ionekanaler | |
| BRPI0508254A (pt) | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos | |
| DK1581235T3 (da) | Anvendelse af spongosin (2-methoxyadenosin) til behandling af smerte i særdeleshed hyperalgesi | |
| TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
| DK1315506T3 (da) | Phospholipidderivater af valproinsyre og blandinger deraf | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| RS54140B1 (en) | USE OF 24-ORDER | |
| ATE256392T1 (de) | Verwendung von polyaminosäurederivate als konservierungsmittel | |
| DE60329326D1 (de) | Tace inhibitoren | |
| NO20062229L (no) | Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er) | |
| DE60213802D1 (de) | Cak inhibitoren und deren verwendungen | |
| EA200500326A1 (ru) | Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента | |
| CY1108980T1 (el) | Χρηση πολυσουλφωμενων κυκλοδεξτρινων για τη θεραπεια της αρθριτιδας | |
| DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser | |
| WO2005011611A3 (en) | Bicyclic compounds and compositions as pdf inhibitors | |
| BRPI0414423A (pt) | inibidores de pace4, suas composições farmacêuticas e respectivos usos | |
| DK1146866T3 (da) | Metode til behandling af patienter med akne ved administration af cyclisk GMP PDE inhibitator | |
| SE0302253D0 (sv) | Lipase-colipase inhibitor |